ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Leo A. Bockeria
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bockeria, L. A.
Right arrow Articles by Poplavskaya, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bockeria, L. A.
Right arrow Articles by Poplavskaya, L. M.

Ann Thorac Surg 1991;51:563-572
© 1991 The Society of Thoracic Surgeons

Articles

Surgical treatment of the Wolff-Parkinson-White syndrome by epicardial electrical ablation

Leo A. Bockeria, MD, DMS*, Nino I. Kupatadze, MD, Dmitry B. Saprigin, MD, DMS, Irakly P. Aslanidi, MD, CMS, Nickolay A. Chigogidze, MD, CMS, Andrey M. Dyadyurko, MD, Ludmila M. Poplavskaya, MD, CMS

Department of Arrhythmias, A. N. Bakoulev Institute of Cardiovascular Surgery, Academy of Medical Sciences of the USSR, Moscow, USSR

Accepted for publication October 15, 1990.

* Address reprint requests to Dr Bockeria, Bakoulev Institute of Cardiovascular Surgery, Leninsky pr. 8, Moscow, USSR 117049.

A new operation to eliminate accessory pathways—epicardial electrical ablation—is described. In a group of 201 patients without concomitant disease, the mortality rate was 0.5% and the overall efficacy of the operation for free wall accessory pathways, 98%. A retrospective clinical study of 44 unselected patients was performed to examine how safe epicardial electrical ablation is. The criteria for intraoperative effectiveness were disappearance of both the delta wave and retrograde conduction and inability to induce tachycardia. In the postoperative and follow-up periods, the following were reviewed: electrocardiograms; Holter monitor recordings (24 to 26 hours); release of the myocardial-specific isoenzyime of creatine kinase; intracardiac hemodynamics and myocardial contractility (radionuclide methods); selective coronary arteriograms and ventriculograms; mean work capacity (bicycle ergometer); diagnostic transesophageal electrical stimulation; and histology of the area of ablation. The main conclusion of this study is that epicardial electrical ablation is a highly efficient and safe operation for surgical elimination of parietal accessory pathways in patients with Wolff-Parkinson-White syndrome. Its advantages are its technical simplicity and the opportunity to review results immediately during the operation.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
T. Iwa
Epicardial and endocardial cathetar ablation for Wolff-Parkinson-White syndrome
Ann. Thorac. Surg., April 1, 1991; 51(4): 527 - 528.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1991 by The Society of Thoracic Surgeons.